This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It?
This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It? originally appeared on Parade.
I don't know about you, but when I conceptualize over-the-counter medications, I think they're generally safe for people to take. They don't require a prescription, people take them often, and the list goes on.To some degree, that's true. But it's important to know that over-the-counter (OTC) medication is still medication; it's still going to have side effects and interactions. On that note, doctors want to warn about a particular OTC med that may harm your brain health, the science behind the risk and safer alternatives to consider.🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊
The medication ingredients in question are doxylamine succinate, which is found in certain sleep aids (like Unisom) and allergy medications, like first-generation antihistamines (such as hydroxyzine, or Vistaril/Atarax, and diphenhydramine, or Benadryl. It can have cognitive side effects in the long term and short term, though the former are more serious—think increased dementia risk.'Doxylamine succinate, a first-generation antihistamine, can have negative impacts on brain health, especially when patients use high doses, frequently and for a long period,' confirms , an allergist at Memorial Hermann.Immediate impacts, she says, include confusion, drowsiness and dizziness. Prolonged use, however, can lead to cognitive decline, memory loss, increased risk of dementia and delirium, especially in older patients.Related: This 3-Minute Habit Could Help You Sleep Through the Night
Dr. Sanjay Kamboj, MD, an associate professor of medicine and an allergy and immunology specialist at LCMC Health, agrees. 'Cumulative use over time may lead to neurodegenerative changes or exacerbate existing risk factors for dementia,' he says. 'Short-term, occasional use of doxylamine in healthy adults is generally considered safe, with mild and temporary side effects such as dry mouth, drowsiness or grogginess.'The former has been noted in research, too: A 2015 study in JAMA Internal Medicine concluded 'higher cumulative anticholinergic use is associated with an increased risk for dementia.' But how does it happen?
'These medications block acetylcholine, a neurotransmitter essential for memory, attention and learning,' explains , sleep science advisor at Aeroflow Sleep, a board-certified sleep medicine physician and a pediatric neurologist. 'Over time, this interference may contribute to structural and functional changes in the brain.'
, a clinical pharmacy specialist in UI Health Care's Allergy/Immunology Clinic, adds that 'acetylcholine is a key chemical involved in promoting wakefulness and arousal,' so naturally, when it's blocked, a person might feel drowsy or sedated.Other common risks that doctors mention include daytime drowsiness, cognitive impairment and somnolence, or severe drowsiness. Further, the latter can impair mental alertness and increase the risk of falls or accidents, Dr. McDanel says.
Related: New Study Reveals Surprising Factor That May Increase Dementia Risk
This is particularly true for older adults who take this medication. 'In older adults, reduced brain reserve makes them more vulnerable to these effects,' Dr. Kamboj explains.
In fact, Dr. Nguyen would say it's 'very risky' for elderly patients to take a high dosage of doxylamine succinate for a prolonged period. The level of risk depends on the dose, duration and individual factors, McDanel adds, like age, other medications taken and overall brain health.
Within certain parameters, it *can* be safe—and even helpful and recommended. 'Generally speaking, doxylamine can be safe when used in the lowest effective dose for the shortest duration possible,' Dr. McDanel says. 'It is even recommended fairly regularly for pregnant women to help with nausea as it is effective for this, along with vitamin B6, and is safe for the fetus.'
Since the safety profile is so individualized, your best bet is to talk to your primary care provider, who knows your history.
It's also worth noting that when it comes to sleep, medication may not be the answer we would assume it to be. 'They don't provide the deep, restorative sleep that our brains need,' Dr. Allen says. 'In fact, they can disrupt the natural sleep architecture, leading to less REM sleep, which is crucial for memory consolidation and emotional regulation.'
If you need more long-term support with allergies or sleep, other options are probably safer bets. Ahead, doctors share tips and treatments to consider.
Try a newer antihistamine, like loratadine (Claritin), cetirizine (Zyrtec) or fexofenadine (Allegra). Dr. Allen says they're generally safer because they don't cross the blood-brain barrier as easily and have fewer side effects.
Second-generation antihistamines are also less likely to make you drowsy, a major complaint with first-generation antihistamines. 'Allergists often recommend these over first-generation antihistamines due to the lower chance of causing sedation, while maintaining the same, if not more, clinical efficacy for treating allergic conditions,' Dr. McDanel adds.
She also encourages steroid nasal sprays, addressing underlying medical conditions and talking to your healthcare provider.
Additionally, Dr. Nguyen mentions prescription medication, such as montelukast, and allergy shots. 'Allergy immunotherapy (allergy shots) is the most effective treatment for moderate to severe allergies,' she adds.
Related: FDA Warns of Newly Identified 'Severe' Risk of Popular Over-the-Counter Allergy Medications
If you struggle with sleep, Dr. Allen has several suggestions. His first recommendation is cognitive behavioral therapy for insomnia (CBT-I). 'This is the gold standard for chronic sleep problems,' he says.
Sleep hygiene is still important too. Need a refresher on what that looks like? Dr. Allen encourages the following:
Establishing a consistent sleep routine
Limiting screen time before bed
Avoiding stimulants late in the day
Creating a cool, dark sleeping environment
Talking to a doctor about medication (or supplements) if necessary
Dr. Nguyen agrees that CBT-I and good sleep habits are good options. 'This is considered the safest way to treat insomnia,' she explains.
And again, this long-term concern about doxylamine and brain health doesn't mean the medication is totally off limits. 'Occasional use (e.g., for a bad cold or jet lag) is not known to pose major harm in healthy adults,' Dr. Kamboj says. 'The concern arises with habitual or long-term use, particularly in older individuals.'
Up Next:Dr. Duyen Nguyen, DO, an allergist
Dr. Sanjay Kamboj, MD, an allergy and immunology specialist
Dr. Chris Allen, MD, a board-certified sleep medicine physician and a pediatric neurologist
Dr. Deanna McDanel, PharmD, a clinical pharmacy specialist
Cumulative Use of Strong Anticholinergics and Incident Dementia, JAMA Internal Medicine
This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It? first appeared on Parade on Jun 17, 2025
This story was originally reported by Parade on Jun 17, 2025, where it first appeared.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
13 minutes ago
- CBS News
At least 3% of measles cases this year were in people who were fully vaccinated, CDC says
At least 3% of measles cases confirmed so far this year have been in people who received two doses of the measles vaccine, meaning they were fully vaccinated, the Centers for Disease Control and Prevention says. About three dozen of the nearly 1,200 measles infections in 2025 have been in people with two vaccine doses, the agency said Friday in its weekly update on cases. An additional 2% of cases were in people who received at least one dose of the measles vaccine. Many of the cases were in Texas, which on Tuesday counted a 21st confirmed measles case in someone with at least two doses of the vaccine. The first 20 cases did not result in hospitalizations, Lara Anton, a spokesperson for the Texas Department of State Health Services, said Monday. Those cases were in children 8 years old or younger. Anton did not immediately respond to a request for more information about the additional case, which was reported on Tuesday after she spoke to CBS News. The first 20 cases also did not include people who received their second dose as a result of post-exposure prophylaxis, Anton said. Post-exposure prophylaxis is offering someone a drug or vaccine after they are exposed to a germ, to reduce the chance they will be infected or develop severe disease. The CDC says people exposed to measles can get vaccinated within 72 hours of when they were first exposed, if they are not fully immunized. "If administered within 72 hours of initial measles exposure, MMR vaccine might provide some protection against infection or modify the clinical course of disease," the agency's recommendations say. Texas has seen a deadly outbreak of the highly contagious virus this year. While cases there have recently slowed, CDC officials have said that authorities have been tracking more outbreaks in other communities across the U.S. linked to travel outside and inside the country. "Additional cases have been seeded from the outbreak in Texas, as well as related outbreaks in Mexico and Canada. Additionally, measles importation from international travel continues, especially as the busy summer of travel season ramps up," Brian Wakeman, deputy lead of the CDC's measles laboratory task force, said Monday. Wakeman, who spoke on a nationwide call for testing laboratories, said the U.S. is now on pace to top the 1,274 cases of measles seen in 2019. That was the most cases the U.S. has seen in a single year since endemic spread of the virus was declared "eliminated" at the end of the 20th century. "We're also on pace to be the greatest number of measles cases since the early 90s," Wakeman said. Six cases of measles in people who received at least two doses of the vaccine have also been in Colorado, that state's health department says. "None of the six cases with 2+ doses were seniors or required hospitalization," Hope Shuler, a spokesperson for the Colorado Department of Public Health and Environment, said in an email. Health authorities and experts have called for some seniors to check if they need a measles booster, especially if they are planning to travel, because of the kind of measles vaccines that were used before 1968. "That group is unlikely to have robust immunity from infection, because at that point in time, they were using less effective vaccines," said Dr. Celine Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News. Colorado says many of its vaccinated cases have been in residents who were exposed during travel to other parts of the world facing large outbreaks like Canada and Europe. The state previously said it had linked multiple cases to an infectious traveler who exposed others at Denver International Airport and on a Turkish Airlines flight. The CDC has also issued new guidance for summer camps to prepare for the threat of measles spread this year, including urging camp operators to check for documentation of immunity among staff and children. Measles vaccines are 97% effective at preventing measles after two doses and 93% after one dose, the CDC says.


Washington Post
17 minutes ago
- Washington Post
FDA to offer faster drug reviews to companies promoting 'national priorities'
WASHINGTON — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting 'the health interests of Americans,' under a new initiative announced Tuesday. Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases . Regular drug reviews take about 10 months. Since arriving at the FDA in April, Makary has repeatedly told FDA staff they need to 'challenge assumptions' and rethink procedures. In a medical journal commentary published last week, Makary suggested the agency could conduct 'rapid or instant reviews,' pointing to the truncated process used to authorize the first COVID-19 vaccines under Operation Warp Speed. For the new program, the FDA will issue a limited number of 'national priority vouchers' to companies 'aligned with U.S. national priorities,' the agency said in a statement. The special designation will give the selected companies access to extra FDA communications, streamlined staff reviews and the ability to submit much of their product information in advance. Speeding up drug approvals has long been a priority of the pharmaceutical industry, which has successfully lobbied Congress to create a variety of special programs and pathways for faster reviews. Many aspects of the plan announced Tuesday overlap with older programs. But the broad criteria for receiving a voucher will give FDA officials unprecedented discretion in deciding which companies can benefit from the fastest reviews. 'The ultimate goal is to bring more cures and meaningful treatments to the American public,' Makary said in a statement. Makary previously said the FDA should be willing to ease its scientific requirements for certain drugs, for instance, by not always requiring randomized studies in which patients are tracked over time to track safety and effectiveness. Such trials are generally considered the gold standard of medical research, though the FDA has increasingly been willing to accept smaller, less-definitive studies for rare or life-threatening diseases . In several recent cases , the FDA has faced criticism for approving drugs based on preliminary data that didn't ultimately show benefits for patients. The push to rapidly accelerated drug approvals is the opposite approach that Makary and his boss, Health Secretary Robert F. Kennedy Jr. , have taken on vaccines. Promising a 'return to gold-standard science,' Kennedy previously announced that all new vaccines would have to be compared to placebo, or a dummy shot, to win approval. Kennedy and Makary also have announced a stricter policy on seasonal updates to COVID-19 shots, saying they will have to undergo new testing before they can be approved for use in healthy children and most adults. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.


CNET
20 minutes ago
- CNET
Jell-O and Kool-Aid Will No Longer Contain Artificial Dyes. This Is What's Replacing Them.
Following the FDA's banning of Red Dye No. 3 in food and ingested drugs in January and the approval of three natural food colors in May, Secretary of Health and Human Services Robert F. Kennedy Jr. asked that food manufacturers remove eight petroleum-based food dyes from their products by the end of 2026. Now, Kraft Heinz, the company behind Jell-O and Kool-Aid, announced that it plans to remove artificial dyes from all its US products before the end of 2027, according to an exclusive with the Wall Street Journal. "The vast majority of our products use natural or no colors, and we've been on a journey to reduce our use of FD&C colors across the remainder of our portfolio," Pedro Navio, Kraft Heinz's North America president, told Wall Street Journal. According to the company, about 90% of its US product sales don't use artificial dyes. Those that do include familiar brand names like Jell-O, Kool-Aid, Heinz relish, Jet-Puffed products and Crystal Light. For those products, it will either remove the artificial dyes if the color is not critical to the product, replace them with natural food colors (which may be a different color) or reinvent certain colors. 3 ways to avoid artificial food dyes Healthline reports that there is no conclusive evidence that food dyes pose a risk for most people. However, more research is needed. In the meantime, if artificial food dyes are something you want to avoid, here are steps you can take to remove them from your kitchen: Read the labels: Not sure if a certain food product contains artificial dyes? The quickest way to find out is by reading the label to see if any dyes are listed. Three of the most common are Red Dye No. 40, Yellow Dye No. 5 and Yellow Dye No. 6. Reduce packaged food: Packaged foods are typically ultra-processed, which means that they are primarily made from substances -- like fats, added sugars and starches -- that are extracted from foods, according to Harvard Health Publishing. They are also more likely to contain artificial dyes. Embrace a balanced diet: As you reduce packaged foods, add in foods like colorful veggies and fruits, whole grains, protein and healthy fats. And make sure you're drinking enough water.